Insider · CIK 0001222082

BUTITTA CYNTHIA M

Reports to the SEC for 6 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001222082

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-29	AUTLAutolus Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+31.7K sh	—	—	31,667
2026-06-29	AUTLAutolus Therapeutics plc · Share Option (Right to Buy)A Award	Director	AAward	+47.5K sh	—	—	47,500
2026-06-22	URGNUroGen Pharma Ltd. · Stock Option (right ot buy)A Award	Director	AAward	+10K sh	—	—	10,000
2026-06-22	URGNUroGen Pharma Ltd. · Restricted Stock UnitA Award	Director	AAward	+8,000 sh	—	—	8,000
2026-06-18	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+29.5K sh	—	—	29,500
2025-11-26	URGNUroGen Pharma Ltd. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	6,000
2025-11-26	URGNUroGen Pharma Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	—	—	2,000
2025-08-26	URGNUroGen Pharma Ltd. · Restricted Stock UnitA Award	Director	AAward	+8,000 sh	—	—	8,000
2025-08-26	URGNUroGen Pharma Ltd. · Stock Option (right ot buy)A Award	Director	AAward	+10K sh	—	—	10,000
2025-06-12	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2025-06-11	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24.2K sh	—	—	24,150
2024-08-06	URGNUroGen Pharma Ltd. · Stock Option (right ot buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-06-20	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2024-06-14	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23K sh	—	—	23,000
2023-09-07	URGNUroGen Pharma Ltd. · Stock Option (right ot buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-06-27	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2023-06-16	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21.5K sh	—	—	21,520
2022-06-17	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21.5K sh	—	—	21,520
2022-06-16	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21.5K sh	—	—	21,520
2022-06-09	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.9K sh	—	—	19,872
2022-06-08	URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-06-17	IPSCCentury Therapeutics, Inc. · Option (right to buy)A Award	Director	AAward	+19.9K sh	—	—	19,872
2021-06-09	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21.5K sh	—	—	21,520
2021-06-07	URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-11-18	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.5K sh	—	—	21,520
2020-09-16	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−83.9K sh	—	—	0
2020-09-16	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+83.9K sh	$4.41	+$370K	83,876
2020-08-12	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+83.9K sh	—	—	83,876
2020-06-08	URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-06-03	URGNUroGen Pharma Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-10-03	Kite Pharma, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−51.6K sh	$128.04	−$6.6M	0
2017-10-03	Kite Pharma, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−37.2K sh	—	—	0
2017-10-03	Kite Pharma, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−44.1K sh	$178.65	−$7.88M	0
2017-10-03	Kite Pharma, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−36.3K sh	—	—	0
2017-10-03	Kite Pharma, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−28.9K sh	$116.13	−$3.36M	0
2017-10-03	Kite Pharma, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−121K sh	$163.00	−$19.8M	0
2017-10-03	Kite Pharma, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−23.4K sh	—	—	0
2017-10-03	Kite Pharma, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−28K sh	—	—	0
2017-10-03	Kite Pharma, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−90.6K sh	—	—	0
2017-10-03	Kite Pharma, Inc.D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−93.7K sh	—	—	0
2017-09-25	Kite Pharma, Inc.S Sale	Chief Operating Officer	SSale	−4,228 sh	$179.66	−$760K	121,567
2017-09-25	Kite Pharma, Inc.A Award	Chief Operating Officer	AAward	+8,000 sh	—	—	125,795
2017-09-21	Kite Pharma, Inc.G Gift	Chief Operating Officer	GGift	−27.9K sh	—	—	93,667
2017-08-10	Kite Pharma, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+15K sh	$1.35	+$20.3K	132,795
2017-08-10	Kite Pharma, Inc.S Sale	Chief Operating Officer	SSale	−5,800 sh	$121.03	−$702K	117,795
2017-08-10	Kite Pharma, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−15K sh	—	—	80,394
2017-08-10	Kite Pharma, Inc.S Sale	Chief Operating Officer	SSale	−9,200 sh	$120.52	−$1.11M	123,595
2017-07-10	Kite Pharma, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−15K sh	—	—	95,394
2017-07-10	Kite Pharma, Inc.S Sale	Chief Operating Officer	SSale	−5,000 sh	$105.50	−$528K	117,795
2017-07-10	Kite Pharma, Inc.S Sale	Chief Operating Officer	SSale	−1,100 sh	$102.81	−$113K	122,795

Recent filings

Accepted (ET)
Jul 14
BUTITTA CYNTHIA M0001730463-26-000097
SEC(opens sec.gov)
Jun 244
BUTITTA CYNTHIA M0001437749-26-021513
SEC(opens sec.gov)
Jun 234
BUTITTA CYNTHIA M0001222082-26-000004
SEC(opens sec.gov)
Dec 14
BUTITTA CYNTHIA M0001437749-25-036565
SEC(opens sec.gov)
Aug 274
BUTITTA CYNTHIA M0001437749-25-027879
SEC(opens sec.gov)
Jun 164
BUTITTA CYNTHIA M0001062993-25-011783
SEC(opens sec.gov)
Jun 134
BUTITTA CYNTHIA M0001415889-25-017233
SEC(opens sec.gov)
Aug 84
BUTITTA CYNTHIA M0001437749-24-025291
SEC(opens sec.gov)
Jun 214
BUTITTA CYNTHIA M0001062993-24-012904
SEC(opens sec.gov)
Jun 184
BUTITTA CYNTHIA M0001415889-24-017441
SEC(opens sec.gov)
Sep 84
BUTITTA CYNTHIA M0001437749-23-025485
SEC(opens sec.gov)
Jun 294
BUTITTA CYNTHIA M0001062993-23-014169
SEC(opens sec.gov)
Jun 214
BUTITTA CYNTHIA M0001415889-23-010101
SEC(opens sec.gov)
Jun 274/A
BUTITTA CYNTHIA M0001415889-22-006962
SEC(opens sec.gov)
Jun 174
BUTITTA CYNTHIA M0001415889-22-006781
SEC(opens sec.gov)
Jun 104
BUTITTA CYNTHIA M0001437749-22-014773
SEC(opens sec.gov)

Companies

Address

THE MEDIAWORKS, WHITE CITY C/O AUTOLUS THERAPEUTICS PLC

LONDON, W12 7FP